Search research articles
Contact Us
Filters
Showing results (391-400 of 529) with videos related to
Page
of 53
Sort By:
Cancers
|
September 10, 2021
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
Er Yue, Guangchao Yang, Yuanfei Yao, et al.
Journal of Clinical Medicine
|
November 26, 2022
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans
Linda D Bosserman, Isa Mambetsariev, Colton Ladbury, et al.
BJU International
|
November 8, 2008
FYN is overexpressed in human prostate cancer
Edwin M Posadas, Hikmat Al-Ahmadie, Victoria L Robinson, et al.
The Journal of Biological Chemistry
|
March 18, 2014
Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells
Peter V Usatyuk, Panfeng Fu, Vijay Mohan, et al.
Translational Lung Cancer Research
|
June 15, 2026
Case report: durable response to osimertinib, radiotherapy, and chemotherapy combination in advanced non-small cell lung cancer with atypical metastasis
Javier Arias-Romero, Isa Mambetsariev, Jeremy Fricke, et al.
Genes, Chromosomes & Cancer
|
August 19, 2008
Expression and mutational analysis of MET in human solid cancers
Patrick C Ma, Maria S Tretiakova, Alexander C MacKinnon, et al.
Oncotarget
|
June 1, 2016
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma
Cleo E Rolle, Yi-Hung Carol Tan, Tanguy Y Seiwert, et al.
Journal of Clinical Medicine
|
June 19, 2024
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies
Sravani Ramisetty, Ayalur Raghu Subbalakshmi, Siddhika Pareek, et al.
The Journal of Biological Chemistry
|
April 3, 2010
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation
Leonardo Faoro, Patrick A Singleton, Gustavo M Cervantes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2014
Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer
Federico Innocenti, Richard L Schilsky, Jacqueline Ramírez, et al.
Page
of 53
Search research articles
Search
Showing results (391-400 of 529) with videos related to
Sort By:
Page
of 53
Cancers
|
September 10, 2021
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer Treatment
Er Yue, Guangchao Yang, Yuanfei Yao, et al.
Journal of Clinical Medicine
|
November 26, 2022
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans
Linda D Bosserman, Isa Mambetsariev, Colton Ladbury, et al.
BJU International
|
November 8, 2008
FYN is overexpressed in human prostate cancer
Edwin M Posadas, Hikmat Al-Ahmadie, Victoria L Robinson, et al.
The Journal of Biological Chemistry
|
March 18, 2014
Role of c-Met/phosphatidylinositol 3-kinase (PI3k)/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells
Peter V Usatyuk, Panfeng Fu, Vijay Mohan, et al.
Translational Lung Cancer Research
|
June 15, 2026
Case report: durable response to osimertinib, radiotherapy, and chemotherapy combination in advanced non-small cell lung cancer with atypical metastasis
Javier Arias-Romero, Isa Mambetsariev, Jeremy Fricke, et al.
Genes, Chromosomes & Cancer
|
August 19, 2008
Expression and mutational analysis of MET in human solid cancers
Patrick C Ma, Maria S Tretiakova, Alexander C MacKinnon, et al.
Oncotarget
|
June 1, 2016
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma
Cleo E Rolle, Yi-Hung Carol Tan, Tanguy Y Seiwert, et al.
Journal of Clinical Medicine
|
June 19, 2024
Leveraging Cancer Phenotypic Plasticity for Novel Treatment Strategies
Sravani Ramisetty, Ayalur Raghu Subbalakshmi, Siddhika Pareek, et al.
The Journal of Biological Chemistry
|
April 3, 2010
EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation
Leonardo Faoro, Patrick A Singleton, Gustavo M Cervantes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2014
Dose-finding and pharmacokinetic study to optimize the dosing of irinotecan according to the UGT1A1 genotype of patients with cancer
Federico Innocenti, Richard L Schilsky, Jacqueline Ramírez, et al.
Page
of 53